默沙东（Merck & Co Inc）的关键监管节点即将到来——根据《处方药使用者费用法案》（PDUFA）规定，美国食品药品监督管理局（FDA）对其新药申请作出最终决定的行动日期定为10月10日。这一日期标志着公司研发管线中重要产品迈向商业化的重要一步。
默沙东（Merck & Co Inc）的关键监管节点即将到来——根据《处方药使用者费用法案》（PDUFA）规定，美国食品药品监督管理局（FDA）对其新药申请作出最终决定的行动日期定为10月10日。这一日期标志着公司研发管线中重要产品迈向商业化的重要一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.